IDEXX LABORATORIES INC /DE Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax
IDEXX LABORATORIES INC /DE (IDXX) reported Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax of -$379.00 thousand for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-01.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax · last filed 2018-08-01
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), reclassification adjustment from aoci on derivatives, tax for the quarter ending 2018-06-30 was -$379.00K, a 235.36% decline year-over-year.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), reclassification adjustment from aoci on derivatives, tax for the quarter ending 2018-03-31 was $250.00K.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), reclassification adjustment from aoci on derivatives, tax for the quarter ending 2017-12-31 was $572.00K, a 54.68% decline year-over-year.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), reclassification adjustment from aoci on derivatives, tax for the quarter ending 2017-09-30 was $333.00K.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), reclassification adjustment from aoci on derivatives, tax for fiscal 2017 was $224.00K, a 76.40% decline from fiscal 2016.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), reclassification adjustment from aoci on derivatives, tax for fiscal 2016 was $949.00K, a 83.79% decline from fiscal 2015.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), reclassification adjustment from aoci on derivatives, tax for fiscal 2015 was $5.85M, a 674.21% increase from fiscal 2014.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), reclassification adjustment from aoci on derivatives, tax for fiscal 2014 was $756.00K, a 11.34% increase from fiscal 2013.
| Period end | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax 3 month | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax 3 month as first filed | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax 6 month | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax 6 month as first filed | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax 9 month | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax 9 month as first filed | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax 12 month | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-06-30 | -$379.00K 10-Q · filed 2018-08-01 | -$629.00K 10-Q · filed 2018-08-01 | $443.00K derived: sum of 3 quarters · filed 2018-08-01 | $776.00K derived: sum of 4 quarters · filed 2018-08-01 | ||||
| 2018-03-31 | $250.00K 10-Q · filed 2018-05-04 | $822.00K derived: sum of 2 quarters · filed 2018-05-04 | $1.16M derived: sum of 3 quarters · filed 2018-05-04 | $1.44M derived: sum of 4 quarters · filed 2018-08-01 | ||||
| 2017-12-31 | $572.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $905.00K derived: sum of 2 quarters · filed 2018-02-16 | $1.19M derived: sum of 3 quarters · filed 2018-08-01 | $224.00K 10-K · filed 2018-02-16 | ||||
| 2017-09-30 | $333.00K 10-Q · filed 2017-10-31 | $613.00K derived: sum of 2 quarters · filed 2018-08-01 | -$348.00K 10-Q · filed 2017-10-31 | $1.47M derived: sum of 4 quarters · filed 2018-08-01 | ||||
| 2017-06-30 | $280.00K 10-Q · filed 2018-08-01 | -$280.00K 10-Q · filed 2017-08-01 | $681.00K 10-Q · filed 2018-08-01 | -$681.00K 10-Q · filed 2017-08-01 | $1.14M derived: sum of 3 quarters · filed 2018-08-01 | $944.00K derived: sum of 4 quarters · filed 2018-08-01 | ||
| 2017-03-31 | -$401.00K 10-Q · filed 2018-05-04 | $401.00K 10-Q · filed 2017-04-28 | $861.00K derived: sum of 2 quarters · filed 2018-05-04 | $664.00K derived: sum of 3 quarters · filed 2018-05-04 | $718.00K derived: sum of 4 quarters · filed 2018-05-04 | |||
| 2016-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $1.06M derived: sum of 2 quarters · filed 2018-02-16 | $1.12M derived: sum of 3 quarters · filed 2018-02-16 | $949.00K 10-K · filed 2018-02-16 | ||||
| 2016-09-30 | -$197.00K 10-Q · filed 2017-10-31 | -$143.00K derived: sum of 2 quarters · filed 2017-10-31 | -$313.00K 10-Q · filed 2017-10-31 | $9.96M derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2016-06-30 | $54.00K 10-Q · filed 2017-08-01 | -$116.00K 10-Q · filed 2017-08-01 | $10.16M derived: sum of 3 quarters · filed 2018-02-16 | $8.78M derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2016-03-31 | $170.00K 10-Q · filed 2017-04-28 | $10.10M derived: sum of 2 quarters · filed 2018-02-16 | $8.73M derived: sum of 3 quarters · filed 2018-02-16 | $7.28M derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2015-12-31 | $9.93M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $8.56M derived: sum of 2 quarters · filed 2018-02-16 | $7.11M derived: sum of 3 quarters · filed 2018-02-16 | $5.85M 10-K · filed 2018-02-16 | ||||
| 2015-09-30 | -$1.37M 10-Q · filed 2016-11-01 | -$2.83M derived: sum of 2 quarters · filed 2016-11-01 | -$4.08M 10-Q · filed 2016-11-01 | -$840.00K derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-06-30 | -$1.45M 10-Q · filed 2016-08-02 | -$2.70M 10-Q · filed 2016-08-02 | $534.00K derived: sum of 3 quarters · filed 2017-02-17 | $467.00K derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-03-31 | $1.25M 10-Q · filed 2016-04-29 | $1.99M derived: sum of 2 quarters · filed 2017-02-17 | $1.92M derived: sum of 3 quarters · filed 2017-02-17 | $2.06M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2014-12-31 | $732.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $665.00K derived: sum of 2 quarters · filed 2017-02-17 | $803.00K derived: sum of 3 quarters · filed 2017-02-17 | $756.00K 10-K · filed 2017-02-17 | ||||
| 2014-09-30 | -$67.00K 10-Q · filed 2015-10-28 | $67.00K 10-Q · filed 2014-10-24 | $71.00K derived: sum of 2 quarters · filed 2015-10-28 | $24.00K 10-Q · filed 2015-10-28 | -$24.00K 10-Q · filed 2014-10-24 | $255.00K derived: sum of 4 quarters · filed 2016-02-17 | ||
| 2014-06-30 | $138.00K 10-Q · filed 2015-07-30 | $91.00K 10-Q · filed 2015-07-30 | $322.00K derived: sum of 3 quarters · filed 2016-02-17 | $651.00K derived: sum of 4 quarters · filed 2016-02-17 | ||||
| 2014-03-31 | $47.00K 10-Q · filed 2015-04-28 | -$47.00K 10-Q · filed 2014-04-25 | $184.00K derived: sum of 2 quarters · filed 2016-02-17 | $513.00K derived: sum of 3 quarters · filed 2016-02-17 | $292.00K derived: sum of 4 quarters · filed 2016-02-17 | |||
| 2013-12-31 | $137.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-17 | $466.00K derived: sum of 2 quarters · filed 2016-02-17 | $245.00K derived: sum of 3 quarters · filed 2016-02-17 | $679.00K 10-K · filed 2016-02-17 | -$679.00K 10-K · filed 2014-02-18 | |||
| 2013-09-30 | $329.00K 10-Q · filed 2014-10-24 | $108.00K derived: sum of 2 quarters · filed 2014-10-24 | $542.00K 10-Q · filed 2014-10-24 | $305.00K derived: sum of 4 quarters · filed 2015-02-17 | ||||
| 2013-06-30 | -$221.00K 10-Q · filed 2014-07-25 | -$213.00K 10-Q · filed 2014-07-25 | -$24.00K derived: sum of 3 quarters · filed 2015-02-17 | $371.00K derived: sum of 4 quarters · filed 2015-02-17 | ||||
| 2013-03-31 | $8.00K 10-Q · filed 2014-04-25 | $197.00K derived: sum of 2 quarters · filed 2015-02-17 | $592.00K derived: sum of 3 quarters · filed 2015-02-17 | |||||
| 2012-12-31 | $189.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $584.00K derived: sum of 2 quarters · filed 2015-02-17 | $1.62M 10-K · filed 2015-02-17 | -$1.62M 10-K · filed 2014-02-18 | ||||
| 2012-09-30 | $395.00K 10-Q · filed 2013-10-22 | $1.43M 10-Q · filed 2013-10-22 | ||||||
| 2011-12-31 | $1.94M 10-K · filed 2014-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |